Title: RIPK1 inhibition leads to lysosome stability via
Tags: #reading_note 


# Notes

# Summary
This study investigates the role of receptor-interacting protein kinase 1 (RIPK1) in ischemic astrocyte injury and its regulation of lysosomal stability through heat shock proteins. Previous work showed that RIPK1/RIPK3 activation mediates astrocyte necroptosis in ischemic models, partly by increasing lysosomal membrane permeability (LMP) and cathepsin release. However, the exact mechanism remained unclear.

The researchers demonstrate that knockdown of RIPK1 or treatment with the inhibitor necrostatin-1 (Nec-1) reduces LMP, protects lysosomal membranes, and decreases ischemic astrocyte damage. This protection is linked to the upregulation of Hsp70.1B, a chaperone protein localized at the lysosomal membrane. Hsp70.1 stabilizes lysosomes during stress, and RIPK1 inhibition enhances its expression and localization. Mechanistically, RIPK1 knockdown reduces cytoplasmic Hsp90 and its binding to Hsf1, thereby facilitating Hsf1 nuclear translocation and transcriptional activation of Hsp70.1B.

Functional studies confirmed that Hsp70.1B knockdown worsened ischemic injury: it increased infarct size, aggravated behavioral deficits, decreased lysosomal integrity, and blocked Nec-1-mediated protection. This highlights Hsp70.1B as an essential mediator of lysosomal stability. In contrast, compensatory effects from Hsp70.1A, a closely related isoform, were insufficient.

The authors propose that RIPK1 and Hsp90 form a stabilizing complex. Inhibition of RIPK1 not only destabilizes this complex but also promotes Hsp90 degradation, enhancing Hsp70.1B transcription via Hsf1 activation. This dual effect—reducing RIPK1 necroptotic signaling while boosting lysosomal protection—contributes to astrocyte survival under ischemic stress.

In summary, the study establishes that RIPK1 inhibition protects lysosomal membranes in ischemic astrocytes through Hsp70.1B-dependent mechanisms. It identifies a novel RIPK1–Hsp90–Hsf1–Hsp70.1B axis linking necroptosis regulation with lysosomal stability, suggesting new therapeutic strategies for ischemic stroke. However, limitations include the non-astrocyte-specific RIPK1 knockdown, leaving possible effects on other glial cells.
# Links
[[@duRIPK1InhibitionContributes2023]]